391 related articles for article (PubMed ID: 18684744)
1. Dose-related patterns of glucocorticoid-induced side effects.
Huscher D; Thiele K; Gromnica-Ihle E; Hein G; Demary W; Dreher R; Zink A; Buttgereit F
Ann Rheum Dis; 2009 Jul; 68(7):1119-24. PubMed ID: 18684744
[TBL] [Abstract][Full Text] [Related]
2. Population-based assessment of adverse events associated with long-term glucocorticoid use.
Curtis JR; Westfall AO; Allison J; Bijlsma JW; Freeman A; George V; Kovac SH; Spettell CM; Saag KG
Arthritis Rheum; 2006 Jun; 55(3):420-6. PubMed ID: 16739208
[TBL] [Abstract][Full Text] [Related]
3. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
[TBL] [Abstract][Full Text] [Related]
4. Intra ocular pressure in chronic users of oral glucocorticoids for rheumatoid arthritis.
Graf C; Cardoso G; Silva MB; Skare TL
Acta Reumatol Port; 2006; 31(2):151-5, 183. PubMed ID: 17058361
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of glucocorticoid-associated adverse events.
McDonough AK; Curtis JR; Saag KG
Curr Opin Rheumatol; 2008 Mar; 20(2):131-7. PubMed ID: 18349741
[TBL] [Abstract][Full Text] [Related]
6. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
[TBL] [Abstract][Full Text] [Related]
7. Barriers in the management of glucocorticoid-induced osteoporosis.
Guzman-Clark JR; Fang MA; Sehl ME; Traylor L; Hahn TJ
Arthritis Rheum; 2007 Feb; 57(1):140-6. PubMed ID: 17266078
[TBL] [Abstract][Full Text] [Related]
8. Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: results of a survey of 985 patients.
Berti D; Moons P; Dobbels F; Deuson R; Janssens A; De Geest S
Clin Ther; 2008 Aug; 30(8):1540-52. PubMed ID: 18803995
[TBL] [Abstract][Full Text] [Related]
9. Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study.
Amann J; Wessels AM; Breitenfeldt F; Huscher D; Bijlsma JWJ; Jacobs JWG; Buttgereit F
Clin Exp Rheumatol; 2017; 35(3):471-476. PubMed ID: 28094753
[TBL] [Abstract][Full Text] [Related]
10. Low-dose glucocorticoid therapy in rheumatoid arthritis.
Trèves R
Rev Rhum Engl Ed; 1995 Nov; 62(10):611-7. PubMed ID: 8624668
[No Abstract] [Full Text] [Related]
11. What do we know about the safety of corticosteroids in rheumatoid arthritis?
Ethgen O; de Lemos Esteves F; Bruyere O; Reginster JY
Curr Med Res Opin; 2013 Sep; 29(9):1147-60. PubMed ID: 23790244
[TBL] [Abstract][Full Text] [Related]
12. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis.
Hoes JN; Jacobs JW; Verstappen SM; Bijlsma JW; Van der Heijden GJ
Ann Rheum Dis; 2009 Dec; 68(12):1833-8. PubMed ID: 19066177
[TBL] [Abstract][Full Text] [Related]
13. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
Grossman LD; Parlan G; Bailey AL; Yee G; Yu M; Chan JY
Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
[TBL] [Abstract][Full Text] [Related]
14. Optimum management of glucocorticoid-treated patients.
Trikudanathan S; McMahon GT
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):262-71. PubMed ID: 18349823
[TBL] [Abstract][Full Text] [Related]
15. Symptom control with low-dose glucocorticoid therapy for rheumatoid arthritis.
Kirwan JR; Buttgereit F
Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv14-20. PubMed ID: 22685271
[TBL] [Abstract][Full Text] [Related]
16. The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: comment on the editorial by Harris.
Jacobs JW; Boers M; Kirwan JR; Bijlsma JW
Arthritis Rheum; 2006 Jun; 54(6):2031-2; author reply 2032. PubMed ID: 16732571
[No Abstract] [Full Text] [Related]
17. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
18. Low dose glucocorticoids in early rheumatoid arthritis.
Strand V; Simon LS
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S186-90. PubMed ID: 14969074
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
[TBL] [Abstract][Full Text] [Related]
20. Shortness of breath at night and health status in congestive heart failure: effects of environmental conditions and health-related and dietary factors.
Goldberg MS; Giannetti N; Burnett RT; Mayo NE; Valois MF; Brophy JM
Environ Res; 2009 Feb; 109(2):166-74. PubMed ID: 19131052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
